INTERNATIONAL PATENT: BIOHAVEN THERAPEUTICS LTD. FILES APPLICATION FOR "USE OF TYK2/JAK1 INHIBITORS TO TREAT AMYLOID-RELATED IMAGING ABNORMALITIES (ARIA)"

GENEVA, Dec. 9 -- BIOHAVEN THERAPEUTICS LTD. (P.O. Box 173Kingston ChambersRoad TownTortola, VG1110) filed a patent application (PCT/IB2025/055519) for "USE OF TYK2/JAK1 INHIBITORS TO TREAT AMYLOID-RELATED IMAGING ABNORMALITIES (ARIA)" on May 28, 2025. With publication no. WO/2025/248468, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHANKAR, Bavani (Biohaven Pharmaceuticals, Inc.215 Church StreetNew Haven, Connecticut 06510), ACKERMAN, Peter Jonathan (Biohaven Pharmaceuticals, Inc.215 Church StreetNew Haven, Connecticu...